发明名称 THERAPEUTIC AGENT FOR OPTIC NERVE DISORDER
摘要 PROBLEM TO BE SOLVED: To find out a new pharmacological action of a urea compound having a structure represented by general formula [I]. SOLUTION: The urea compound having the structure represented by general formula [I] (wherein, A represents a lower alkylene group or a lower alkenylene group; R<SB>1</SB>represents a hydrogen atom, an alkyl group or an alkenyl group, wherein the alkyl group and the alkenyl group may be substituted with an optional substituent; and R<SB>2</SB>and R<SB>3</SB>are each the same or different, and represent each a hydrogen atom or a lower alkyl group, in which the lower alkyl group may be substituted with a monocyclic cycloalkyl group, a polycyclic cycloalkyl group or an aryl group) or salts thereof have an excellent therapeutic action on TRPV1-mediated diseases. COPYRIGHT: (C)2010,JPO&amp;INPIT
申请公布号 JP2010024219(A) 申请公布日期 2010.02.04
申请号 JP20080267027 申请日期 2008.10.16
申请人 SANTEN PHARMACEUT CO LTD 发明人 SASAOKA MASAAKI;SEIKE TOSHIYUKI;KAGEYAMA MASAAKI;TSUJI FUMIO;ONKI KENJI;MURAI MASAAKI
分类号 A61K45/00;A61K31/165;A61K31/4409;A61P27/02;A61P43/00;C07D213/36 主分类号 A61K45/00
代理机构 代理人
主权项
地址
您可能感兴趣的专利